Finance
Markets
No recent trading data. The last price we hold for HCA is from Jun 3 (48 days ago). This symbol may be delisted, renamed, or halted — the figures below reflect its last active session, not the current market.

HCA

stock Healthcare Medical Care Facilities
HCA Healthcare
$363.30 -4.05 (-1.10%) Delayed · quoted 47d ago
Mixed 53% Steady

What the indicators say

Bearish 0 of 5 trend signals bullish
Momentum · RSI 14 Oversold
17
0oversold 30overbought 70100

RSI 17 — oversold: selling looks stretched and may be due for a bounce.

EMA 21 $402.25
Below
Near-term trend is down
SMA 50 $444.05
Below
Medium-term trend is down
SMA 200 $461.99
Below
Long-term trend is down
50 / 200-day
Death cross
50-day below the 200-day — bearish
Supertrend $396.20
Downtrend
Price is below the Supertrend band — bearish

A mechanical reading of the chart’s indicators — not investment advice.

Key statsas of Jun 3

The day open and close within the day's range
Low $358.96 High $367.25
Open
$363.30
-1.10%
Close
$363.30
-1.10%
52-week range where the price sits across its year
52w low $330.00 52w high $556.52
Current
$363.30
Prev close
$367.35
Volume 1.53× the 3-month average
0 avg 2× avg
Today
1.91M
3-mo avg
1.25M

Earningscalendar synced from Yahoo 57d ago

Most recent
Apr 2488 days ago
Next expected
Jul 24in 3 days

Recent earnings dates

  • Apr 24 88 days ago
  • Jan 27 175 days ago
  • Oct 24, 2025 270 days ago
  • Jul 25, 2025 361 days ago

Past earnings dates come from HCA’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.

Fundamentalssynced from SEC 51d ago

Strong

Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), HCA’s fundamentals read as strong overall.

P/E ratio Strong
12.5x

At 12.5x, the price is a reasonable multiple of the company's annual profit.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Fair
0.79%

A 0.8% yield is modest: a small income on top of whatever the share price does.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Fair
9.0%

A 9.0% margin is solid, in the ordinary range for a profitable company.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity No data
—

Shareholder equity is negative, so return on equity is not meaningful.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Strong
11.2%

A 11.2% return on assets is strong; the company squeezes good profit from its assets.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity No data
—

Not enough data to compute debt-to-equity.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Weak
0.97

At 0.97, short-term assets fall short of short-term bills; liquidity is tight.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Fair
+7.1%

Revenue grew 7.1% from the prior year: steady, modest expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Strong
+17.8%

Net income grew 17.8% from the prior year: strong profit expansion.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financialssynced from SEC 51d ago

FY2021FY2022FY2023FY2024FY2025
Revenue $58.8B$60.2B$65.0B$70.6B$75.6B
Net income $7.0B$5.6B$5.2B$5.8B$6.8B
Diluted EPS $21.16$19.15$18.97$22.00$28.33
Dividend / share $1.92$2.24$2.40$2.64$2.88
Total assets $50.7B$52.4B$56.2B$59.5B$60.7B
Total liabilities —————
Shareholder equity $1.5B-$73.0M$1.1B-$2.5B-$6.0B

Leadershipsynced from SEC 56d ago

  • Marks Mike A EVP and CFO
  • Mcalevey Michael R EVP & Chief Legal & Admin Off.
  • Chidsey John Director
  • Deparle Nancy Ann Director
  • Frist Thomas F Iii Director
  • Frist William R Director
  • Johnston Hugh F Director
  • Michelson Michael W Director
  • Riley Wayne Joseph Director
  • Smith Andrea B Director

Officers and board are drawn from HCA’s recent SEC ownership filings (Forms 3, 4 and 5).

Recent leadership changes

Notable recent eventspast year

Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.

Dividendssynced from Yahoo 52d ago

Pays quarterly Strong
2025 total
$2.88
2026 so far
$0.781 payment
2026 projected
$3.12+8.3% vs 2025

Projection scales HCA’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.

Payment history

  • Mar 17 $0.78
  • Dec 15, 2025 $0.72
  • Sep 16, 2025 $0.72
  • Jun 16, 2025 $0.72
  • Mar 17, 2025 $0.72
  • Dec 13, 2024 $0.66
  • Sep 16, 2024 $0.66
  • Jun 14, 2024 $0.66
  • Mar 14, 2024 $0.66
  • Dec 13, 2023 $0.60
  • Sep 14, 2023 $0.60
  • Jun 15, 2023 $0.60
  • Mar 16, 2023 $0.60
  • Dec 13, 2022 $0.56
  • Sep 15, 2022 $0.56
  • Jun 15, 2022 $0.56
  • Mar 16, 2022 $0.56
  • Dec 13, 2021 $0.48
  • Sep 15, 2021 $0.48
  • Jun 15, 2021 $0.48

Recent SEC filingssynced from SEC 51d ago

© 2026 Isaac Bythewood · Some rights reserved